On June 29, Medytox, a bio-pharmaceutical company, announced that it had successfully participated in the '16th Summer Conference of the Korean Society for Anti-Aging Dermatology 2026'.


This conference was organized to share the latest research findings and clinical experiences in the fields of skin anti-aging and clinical anatomy, and was attended by over 400 medical professionals, including dermatologists and other healthcare workers.


Medytox Successfully Participates in the '2026 Summer Conference of the Korean Society for Anti-Aging Dermatology' View original image

On the first day of the conference, Hyechan Jeon, Director of The Seoul Dermatology Clinic; Hwayeong Jeong, Director of Modelro Dermatology Clinic; Youngwoon Park, Director of Villa de Skin Dermatology Clinic; and Miyeon Cho, Professor at Bundang CHA Hospital, held a hands-on seminar on botulinum toxin products and hyaluronic acid fillers for medical professionals at the Medytox Bunker M. The seminar featured the world's first liquid-type botulinum toxin type A product, 'Innotox,' the 150 kDa botulinum toxin type A product, 'Coretox,' as well as hyaluronic acid fillers specialized for midface volume enhancement ('Neuramis Heart') and facial wrinkle improvement ('Neuramis Skin Enhancer'). The speakers introduced the unique characteristics of each product and shared procedural insights, thereby helping participants deepen their understanding and enhance their procedural skills.


On the second day, Medytox operated an exhibition booth within the conference to showcase its medical aesthetics portfolio. In particular, 'Coretox,' as the world's first 150 kDa non-animal derived botulinum toxin product, is expanding its presence in the domestic premium toxin market, and it drew significant attention at this conference as well.


On the same day, Giwoong Hong, Director of Sam Skin Plastic Surgery Clinic, delivered a lecture in a separate session, presenting treatment techniques for deep facial wrinkles and horizontal neck lines using 'Neuramis Skin Enhancer' and mesothreads.



A representative from Medytox stated, "This conference was a meaningful opportunity to share the distinctiveness and clinical utility of our products with medical professionals," adding, "We will continue to foster broad academic exchange with healthcare providers and further solidify our position as a leader in medical aesthetics."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing